Fundraising Fox

Pixelgen

Founded 2020 · 45 employees on LinkedIn · 2 known investors

Pixelgen Technologies develops the Proxiome Kit, powered by its patented Proximity Network Assay, to analyze the spatial organization, abundance, and colocalization of proteins on the surface of single immune cells at nanoscale resolution. It serves researchers in immunology, hematology, cell therapy, and precision medicine with high-dimensional single-cell protein interactomics tools.

BiotechDeep TechHardware

Investors · 2

IndustrifondenStockholm · $1.1M – $4.3M
Navigare VenturesStockholm

In the news

Stockholm’s Pixelgen Technologies secures €13.26 million to advance spatial mapping of cell-surface proteinseu-startups.com · Aug 2026VC funding deals: Alloy Robotics, Axle, Treeline, Turnout - InfotechLeadinfotechlead.com · Aug 2026Flat Capital leads new funding round in life science company Pixelgen Technologies — TradingView Newstradingview.com · Aug 2026Stockholm’s Pixelgen Technologies secures €13.26 million to advance spatial mapping of cell-surface proteins | EU-Startupseu-startups.com · Aug 2026Pixelgen Technologies Closes $15.5M Oversubscribed Series B to Accelerate Global Expansionprnewswire.com · Aug 2026Pixelgen Technologies Raises $15.5M in Series B Fundingfinsmes.com · Aug 2026Pixelgen Technologies Awarded $14.7 Million in Blended Funding from European Innovation Council Acceleratorprnewswire.com · Jun 2025

Frequently asked questions

What does Pixelgen do?
Pixelgen Technologies develops the Proxiome Kit, powered by its patented Proximity Network Assay, to analyze the spatial organization, abundance, and colocalization of proteins on the surface of single immune cells at nanoscale resolution. It serves researchers in immunology, hematology, cell therapy, and precision medicine with high-dimensional single-cell protein interactomics tools.
Who are Pixelgen's investors?
Pixelgen's investors include Industrifonden, Navigare Ventures.